Gene · 8607
Papers1,564
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 1,564
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Regulation of NRF1, a master transcription factor of proteasome genes: implications for cancer and neurodegeneration. | Mol Biol Cell | 2020 | 32924844 | PubTator, text mining | PubMed |
| Resolution of R-loops by INO80 promotes DNA replication and maintains cancer cell proliferation and viability. | Nat Commun | 2020 | 32913330 | PubTator, text mining | PubMed |
| Investigating the Role of Telomere and Telomerase Associated Genes and Proteins in Endometrial Cancer. | Methods Protoc | 2020 | 32899298 | PubTator, text mining | PubMed |
| Genomics and Functional Genomics of Malignant Pleural Mesothelioma. | Int J Mol Sci | 2020 | 32882916 | PubTator, text mining | PubMed |
| A relational database to identify differentially expressed genes in the endometrium and endometriosis lesions. | Sci Data | 2020 | 32859947 | PubTator, text mining | PubMed |
| Identification of Gene Signatures for Diagnosis and Prognosis of Hepatocellular Carcinomas Patients at Early Stage. | Front Genet | 2020 | 32849835 | PubTator, text mining | PubMed |
| Deregulated levels of RUVBL1 induce transcription-dependent replication stress. | Int J Biochem Cell Biol | 2020 | 32846207 | PubTator, text mining | PubMed |
| Gene Regulatory Network Analysis of Perivascular Adipose Tissue of Abdominal Aortic Aneurysm Identifies Master Regulators of Key Pathogenetic Pathways. | Biomedicines | 2020 | 32823940 | PubTator, text mining | PubMed |
| UFMylation maintains tumour suppressor p53 stability by antagonizing its ubiquitination. | Nat Cell Biol | 2020 | 32807901 | PubTator, text mining | PubMed |
| WNT signaling pathway regulator-FRAT2 affects oncogenesis and prognosis of basal-like breast cancer. | J Thorac Dis | 2020 | 32802426 | PubTator, text mining | PubMed |
| Synthetic lethality by targeting the RUVBL1/2-TTT complex in mTORC1-hyperactive cancer cells. | Sci Adv | 2020 | 32789167 | PubTator, text mining | PubMed |
| Quantitative Proteomics Links the LRRC59 Interactome to mRNA Translation on the ER Membrane. | Mol Cell Proteomics | 2020 | 32788342 | PubTator, text mining | PubMed |
| Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | ACS Chem Biol | 2020 | 32786267 | PubTator, text mining | PubMed |
| ZZW-115-dependent inhibition of NUPR1 nuclear translocation sensitizes cancer cells to genotoxic agents. | JCI Insight | 2020 | 32780723 | PubTator, text mining | PubMed |
| Establishment of international autoantibody reference standards for the detection of autoantibodies directed against PML bodies, GW bodies, and NuMA protein. | Clin Chem Lab Med | 2020 | 32776893 | PubTator, text mining | PubMed |
| Acrylamide exposure represses neuronal differentiation, induces cell apoptosis and promotes tau hyperphosphorylation in hESC-derived 3D cerebral organoids. | Food Chem Toxicol | 2020 | 32763439 | PubTator, text mining | PubMed |
| PRMT5 promotes DNA repair through methylation of 53BP1 and is regulated by Src-mediated phosphorylation. | Commun Biol | 2020 | 32759981 | PubTator, text mining | PubMed |
| PDCD6 cooperates with C-Raf to facilitate colorectal cancer progression via Raf/MEK/ERK activation. | J Exp Clin Cancer Res | 2020 | 32746883 | PubTator, text mining | PubMed |
| RUVBL1 is an amplified epigenetic factor promoting proliferation and inhibiting differentiation program in head and neck squamous cancers. | Oral Oncol | 2020 | 32745900 | PubTator, text mining | PubMed |
| PRMT5 function and targeting in cancer. | Cell Stress | 2020 | 32743345 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8607/papers?page=29